DaVita (DVA) vs HCA Healthcare (HCA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
DaVita (DVA) has outperformed HCA Healthcare (HCA) over the past year, gaining 34.9% versus a gain of 0.8%. Over five years, HCA leads with a +78.6% price change compared with +57.5% for DVA. HCA Healthcare is the larger company by market cap ($95.08 billion vs $11.28 billion), about 8.4 times the size.
On valuation, DaVita trades at a lower forward P/E (10.3x vs 13.7x for HCA Healthcare). HCA Healthcare pays a dividend yielding 0.68%, while DaVita does not currently pay one. HCA Healthcare converts more of its revenue into profit, with a net margin of 9.0% versus 5.5%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | DVA | HCA |
|---|---|---|
| Share price | $176.78 | $439.17 |
| Market cap | $11.28B | $95.08B |
| 1-day change | -2.01% | +1.61% |
| YTD return | +55.60% | -5.55% |
| 1-year return | +34.91% | +0.77% |
| 5-year return | +57.54% | +78.61% |
| P/E ratio (TTM) | 14.93 | 14.72 |
| Forward P/E | 10.31 | 13.72 |
| EPS (TTM) | $11.84 | $29.83 |
| Dividend yield | 0.00% | 0.68% |
| Annual dividend | $0.00 | $3.00 |
| Revenue (latest FY) | $13.64B | $75.60B |
| Revenue growth (YoY) | +6.46% | +7.08% |
| Net income (latest FY) | $746.80M | $6.78B |
| Operating margin | 14.98% | — |
| Net margin | 5.47% | 8.97% |
| 52-week high | $247.49 | $556.52 |
| 52-week low | $101.00 | $353.99 |
| Distance from 52-week high | -28.57% | -21.09% |
| Analyst consensus | buy | buy |
| Avg. price target upside | +24.37% | +4.58% |
| Average volume | 776.03K | 1.48M |
| Shares outstanding | 63.80M | 216.50M |
| Employees | 78,000 | 230,000 |
| Sector | Health Care | Health Care |
| Industry | Misc Health and Biotechnology Services | Hospital/Nursing Management |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- HCA Healthcare is about 8.4 times larger than DaVita by market value ($95.08B vs $11.28B).
- DVA has outperformed HCA by 34.1 percentage points over the past year.
About DaVita
DVA stock →DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States.
Health Care · Misc Health and Biotechnology Services · 78,000 employees
About HCA Healthcare
HCA stock →HCA Healthcare, Inc., through its subsidiaries, provides health care services in the United States. The company owns, manages, and operates hospitals, ASCs, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, radiation and oncology therapy centers, as well as rehabilitation and physical therapy centers, physician practices, home health agencies, hospices, outpatient physical therapy providers, home and community-based services providers, and various other facilities.
Health Care · Hospital/Nursing Management · 230,000 employees
DVA vs HCA FAQ
Which is bigger, DaVita or HCA Healthcare?
HCA Healthcare (HCA) is larger, with a market capitalization of $95.08B compared with $11.28B for DaVita (DVA).
Which stock has performed better over the past year, DVA or HCA?
DVA returned +34.91% over the past 12 months, compared with +0.77% for HCA (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, DVA or HCA?
HCA has the lower trailing P/E at 14.7, versus 14.9 for DVA. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, DaVita or HCA Healthcare?
HCA Healthcare pays a dividend yielding 0.68%, while DaVita does not currently pay a regular dividend.
Are DaVita and HCA Healthcare in the same industry?
Both are in the Health Care sector, but in different industries: Misc Health and Biotechnology Services for DaVita and Hospital/Nursing Management for HCA Healthcare.